ProText Mobility, Inc.
TXTM - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$63.3M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $63.30 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | -2.84 |
| Outstanding Shares | 8,791,221,631 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 74 |
|---|---|
| PEG | -446.58 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About ProText Mobility, Inc.
30 employees
CEO: Plooy Du Dylon
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida.